Patients with certain GLP1R variants may experience more pronounced appetite suppression or higher nausea sensitivity, helping your PlexusDx provider personalize both your dose escalation and dietary recommendations for your unique biology
This article provides a research-only overview of dosing ranges observed in studies, summaries of administration methods used in experimental settings, and patterns commonly referenced in scientific and community discussions
The calculation for pI involves averaging the pKa values associated with the carboxyl and the third ionizable group, resulting in a pI of 2.77, expressed as: pI = 1/2 (pKa1 + pKa3)
How can I transition a patient from Zepbound (tirzepatide) to retatrutide, specifying the washout period, starting dose, titration schedule, monitoring (weight, fasting glucose/HbA1c, blood pressure, renal function, gastrointestinal side effects) and contraindications (medullary thyroid carcinoma, multiple endocrine neoplasia type 2)?
It can only be accessed through regulated clinical trials